Approaches of Pediatric Nephrologists to Hypertensive Patients in Turkey (Turkish Pediatric Hypertension Working Group Study)

Basit Öğe Kaydı
dc.authoridDursun, Hasan/0000-0002-8817-494X
dc.authoridGIRISGEN, ILKNUR/0000-0003-2617-4466
dc.authorwosidDursun, Hasan/AAB-7105-2020
dc.authorwosidGIRISGEN, ILKNUR/AAA-5113-2021
dc.contributor.authorKasap-Demir, Belde
dc.contributor.authorTasdemir, Mehmet
dc.contributor.authorOvunc-Hacihamdioglu, Duygu
dc.contributor.authorGirisgen, Ilknur
dc.contributor.authorDursun, Hasan
dc.contributor.authorCivilibal, Mahmut
dc.contributor.authorBenzer, Meryem
dc.date.accessioned2024-06-12T11:03:35Z
dc.date.available2024-06-12T11:03:35Z
dc.date.issued2022
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: We aimed to evaluate the approaches of pediatric nephrologists in our country to the management of childhood hypertension. Methods: The pediatric nephrologists in our country were invited to fill out an online questionnaire including 24 questions. The answers were compared between those working in the field for <= 10 years (Group 1, n =74) and >10 years (Group 2, n = 62). Results: Of 136 participants (M/F = 101/35), 52% were following a single guideline [31% Fourth Report of 2004, 17% European Society of Hypertension in 2016, and 52% American Academy of Pediatrics in 2017], which is more common in Group 1 (P =.035). The most commonly used guideline was American Academy of Pediatrics of 2017 and Group 2 used Fourth Report of 2004 more commonly (P =.042). The most common choice to diagnose hypertension was office + home + ambulatory blood pressure monitoring (59%). The frequency of screening for end-organ damage at first evaluation was 96%. The time to wait for the effect of lifestyle modifications was 3 months in 52%. The first choice medication was angiotensin-converting enzyme inhibitors (49%) or calcium-channel blockers (48%) in non-obese and angiotensin-converting enzyme inhibitors (74%) in obese children. Calcium-channel blockers were more commonly prescribed as the first choice in non-obese children in Group 1 (P =.035). The most accessible emergency drug was esmolol. Conclusion: Despite following recent guidelines, the time spent in the proficiency would change the practices.en_US
dc.identifier.doi10.5152/turkjnephrol.2022.21112
dc.identifier.endpage115en_US
dc.identifier.issn2667-4440
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85130068348en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage110en_US
dc.identifier.trdizinid531308en_US
dc.identifier.urihttps://doi.org/10.5152/turkjnephrol.2022.21112
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/531308
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21703
dc.identifier.volume31en_US
dc.identifier.wosWOS:000834658600004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal Of Nephrologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHypertensionen_US
dc.subjectChildrenen_US
dc.subjectAdolescentsen_US
dc.subjectGuidelinesen_US
dc.subjectClinical Practice Patternsen_US
dc.subjectPulse-Wave Velocityen_US
dc.subjectAdolescents Reference Valuesen_US
dc.subjectIntima-Media Thicknessen_US
dc.subjectBlood-Pressureen_US
dc.subjectHealthy-Childrenen_US
dc.subjectAgeen_US
dc.titleApproaches of Pediatric Nephrologists to Hypertensive Patients in Turkey (Turkish Pediatric Hypertension Working Group Study)en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu